STOCK TITAN
  1. Home
  2. Sec-filings
  3. HCWB
  4. [8-K] HCW Biologics Inc. Reports Material Event

[8-K] HCW Biologics Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock HCWB logo
Hcw Biologics Inc.

NASDAQ:HCWB

HCWB Rankings

#6244 Ranked by Market Cap
N/A Ranked by Dividends

HCWB Latest News

Sep 30, 2025
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment About its Proprietary T-Cell Engager Program
Sep 18, 2025
HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing
Sep 16, 2025
HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development
Sep 9, 2025
HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program
Aug 25, 2025
HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market

HCWB Latest SEC Filings

Sep 5, 2025
[8-K] HCW Biologics Inc. Reports Material Event
Aug 19, 2025
[8-K] HCW Biologics Inc. Reports Material Event
Aug 18, 2025
[10-Q] HCW Biologics Inc. Quarterly Earnings Report
Aug 18, 2025
[8-K/A] HCW Biologics Inc. Amends Material Event Report
Aug 15, 2025
[NT 10-Q] HCW Biologics Inc. SEC Filing

HCWB Stock Data

9.77M
1.56M
27.3%
1%
11.41%
Biotechnology
Pharmaceutical Preparations
Link
United States
MIRAMAR